Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter pylori
jRCT1080222003
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rabeprazole in Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid Tissue and Helicobacter pylori infection, sponsored by Eisai Co., Ltd.
02
Drugs
rabeprazole
03
Conditions
Gastric Marginal Zone B-Cell Lymphoma Of Mucosa-Associated Lymphoid TissueHelicobacter pylori infection
Beyond the preview
Go deeper on jRCT1080222003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222003.